![DOJ Claims Teva Pharmaceuticals Paid Illegal Kickbacks, Artificially Inflated Price Of Drugs - Whistleblower Network News DOJ Claims Teva Pharmaceuticals Paid Illegal Kickbacks, Artificially Inflated Price Of Drugs - Whistleblower Network News](https://whistleblowersblog.org/wp-content/uploads/2020/09/iStock-1181611248-1024x576.jpg)
DOJ Claims Teva Pharmaceuticals Paid Illegal Kickbacks, Artificially Inflated Price Of Drugs - Whistleblower Network News
![Teva stocks fall after company said named in US price-fixing drug 'cartel' probe | The Times of Israel Teva stocks fall after company said named in US price-fixing drug 'cartel' probe | The Times of Israel](https://static.timesofisrael.com/www/uploads/2018/07/teva.jpg)
Teva stocks fall after company said named in US price-fixing drug 'cartel' probe | The Times of Israel
![KYIV, UKRAINE - MAY 28, 2020: Gastroenterology generic drug Omeprazole by TEVA, box and blisters closeup on white. Teva Pharmaceuticals is an American Stock Photo - Alamy KYIV, UKRAINE - MAY 28, 2020: Gastroenterology generic drug Omeprazole by TEVA, box and blisters closeup on white. Teva Pharmaceuticals is an American Stock Photo - Alamy](https://c8.alamy.com/comp/2C6A97H/kyiv-ukraine-may-28-2020-gastroenterology-generic-drug-omeprazole-by-teva-box-and-blisters-closeup-on-white-teva-pharmaceuticals-is-an-american-2C6A97H.jpg)
KYIV, UKRAINE - MAY 28, 2020: Gastroenterology generic drug Omeprazole by TEVA, box and blisters closeup on white. Teva Pharmaceuticals is an American Stock Photo - Alamy
![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678526/5/AJOVY+Image.jpg)
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
![Teva Becomes First Pharmaceutical Company to Execute Sustainability-linked Bond Tied to both Climate and Access to Medicine Targets | Business Wire Teva Becomes First Pharmaceutical Company to Execute Sustainability-linked Bond Tied to both Climate and Access to Medicine Targets | Business Wire](https://mms.businesswire.com/media/20211103005244/en/739014/22/teva_RGB_JPEG.jpg)
Teva Becomes First Pharmaceutical Company to Execute Sustainability-linked Bond Tied to both Climate and Access to Medicine Targets | Business Wire
![Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/510642830861510679/filePointer/510642830861510701/fodoid/510642830861510696/imageType/MEDIUM/inlineImage/true/Teva-announced-launch-of-new-daily-asthma-medicine.png)